Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of Los Angeles Times, shared on X about a recent paper by Tim Cortese published on CancerNetwork:
“The future is here. Cell therapy especially CAR-NK therapy is the next era of cancer care. Especially when you combine cell therapy with cytokines such as ANKTIVA.
Amassing cancer killer cells ImmunityBio Waldenstrom trial open at CSSIFM.org.”
Title: Novel CD19 CAR-NK Therapy Yields Responses in Waldenstrom Macroglobulinemia
More from Pat Soon-Shiong on OncoDaily.